(NewsNation) — A daily pill could be as effective for weight loss as popular drugs like Wegovy and Ozempic, providing an alternative to the injectable medications. The pill, orforglipron, is also a ...

A new GLP-1 pill from Eli Lilly has shown positive results in clinical trials. New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 ...

The first daily weight-loss pill is expected to be available in the UK as soon as 2026 after a trial found it to be effective in treating obesity and diabetes. The drug, developed by Eli Lilly and ...

Ozempic has become somewhat of a buzzword in the Western beauty sphere, making its way from the NHS shelves to Hollywood red carpets. Originally developed as a once-weekly injection for type 2 ...

Orforglibron, a pill form of GLP-1 weight loss injections like Ozempic and Mounjaro, is undergoing clinical trials. Drugmaker Eli Lilly said the first trial showed similar weight loss and diabetes ...

Injectables like Ozempic may be grabbing headlines right now, but some of the best weight-loss pills are a more accessible and practical option for many women. “These oral agents have been around for ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.

Poor tolerability of GLP-1 obesity drugs leads many patients to stop taking them, resulting in gaining back the weight that was lost. Some drug companies are trying to develop other approaches that ...

The U.S. Food and Drug Administration has accepted Novo Nordisk’s application for an oral version of its blockbuster weight loss drug Wegovy. The Danish drugmaker – which has its U.S. headquarters in ...

Every year, millions of Americans turn to weight loss pills, hoping for a simple solution to shed their stubborn pounds. Obesity affects over 40% of U.S. adults today, driving many to seek medication ...